ArticleCancers2026

Functional Precision Oncology in Fibrolamellar Carcinoma: Ex Vivo Identification of Therapeutic Vulnerabilities.

Sabina A Schneider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.